Makers Laboratories

Makers Laboratories FCF Yield

The Free Cash Flow Yield of Makers Laboratories (506919.BO) as of Oct 16, 2026 is 13.00 %. In the previous year, Free Cash Flow Yield was -9.86 % — a change of -231.90% (higher).

FCF Yield

13.00 %

YoY

-231.90%

Last updated:

Free Cash Flow Yield of Makers Laboratories is 2026 13.00 % . Free Cash Flow Yield of Makers Laboratories was 2025 -9.86 % . It decreases by -231.90% higher compared to the previous year.

The Makers Laboratories FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
-2.32 INR
Jan 1, 2019
-4.35 INR
Jan 1, 2020
-5.36 INR
Jan 1, 2022
-1.71 INR
Jan 1, 2023
-26.46 INR
Jan 1, 2024
-7.11 INR
Jan 1, 2025
-9.86 INR
Jan 1, 2026
13.00 INR
The Makers Laboratories FCF Yield history
YEARFCF YieldYoY
13.00 %-231.90%
-9.86 %+38.70%
-7.11 %-73.14%
-26.46 %+1,449.05%
-1.71 %-68.15%
-5.36 %+23.34%
-4.35 %+87.76%
-2.32 %-43.62%
-4.11 %-327.00%
1.81 %-311.32%
-0.86 %-48.38%
-1.66 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Makers Laboratories Stock analysis

What does Makers Laboratories do? Makers Laboratories Ltd is a pharmaceutical company headquartered in Mumbai, India, operating within the Health Care sector. The company has a workforce of 121 employees and went public on July 13, 1993. It manufactures and markets pharmaceutical products, focusing on various therapeutic segments. The company's product portfolio includes formulation brands such as Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (anti-cough range), and Exylin (Amoxycillin range). Additionally, Makers Laboratories offers Inspira retail packs, covering categories like acid regulatory, anthelmintics, anti-allergic, anti-asthmatic, anti-biotics, anti-diabetics, anti-diarrheal, anti-emetics, anti-nauseants, anti-fungal, anti-hypertensives, and other health-related products. The Experia bulk packs division provides bulk pharmaceutical products including amoxycillin 250 mg capsules, betamethasone 0.5 mg tablets, cetirizine HCL 10 mg tablets, chloramphenicol capsules 250 mg, chloroquine phosphate 250 mg tablets, chlorpheniramine maleate 4 mg tablets, ciprofloxacin hydrochloride 250 mg tablets, and similar items. The company's website is https://www.makerslabs.com/. Makers Laboratories Ltd is listed on the Bombay Stock Exchange under the ticker 506919.BO and holds the ISIN INE987A01010. The company operates through the pharmaceuticals segment, emphasizing general health therapeutic areas. It does not disclose specific financial figures or additional details beyond its product lines and operational structure. Makers Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Makers Laboratories stock

Free Cash Flow Yield of Makers Laboratories is 13.00 % in 2026.

Free Cash Flow Yield of Makers Laboratories changed from -9.86 % to 13.00 %, representing a -231.90% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Makers Laboratories since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Makers Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Makers Laboratories

All Key Metrics — Makers Laboratories